Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-06-08A Phase 1, Open-Label, Single-Sequence Study to Examine the Effect of Telaprevir on the Pharmacokinetics of Buprenorphine in Subjects on Stable Buprenorphine/Naloxone Maintenance Therapy
-
CLINICAL_TRIALS study record update · 2011-05-24Screening for Hepatocellular Carcinoma With Triphasic Helical CT vs. US With Alpha-fetoprotein in Patients With Advanced Liver Disease
-
CLINICAL_TRIALS study record update · 2011-05-19A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN
-
CLINICAL_TRIALS study record update · 2011-05-19)A Study to Evaluate the Erythropoietic Response in HCV/HIV Co-Infected Patients Receiving Combination Ribavirin/Interferon Therapy
-
CLINICAL_TRIALS study record update · 2011-05-19Phase I, Double Blind, Randomized, Placebo-controlled Trial in Healthy Subjects to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing, Followed by an Open Label Repeated Dosing Session in 6 HCV genotype1 Infected Patients.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-05-16A Phase Iv Single-Arm Open-Label Non-Randomized Study To Evaluate The Safety And Pharmacokinetics Of Nelfinavir (Viracept, A430) 1250mg Twice Daily (250mg Or 625mg Forms) With Lamivudine/Zidovudine (Combivir) Background Therapy In Hiv/Hepatitis C Virus (Hcv) Co-Infected Subjects With Hepatic Dysfunction.
-
CLINICAL_TRIALS study record update · 2011-04-28Does Vitamin D Supplement Improve SVR in Chronic Hepatitis C (Genotype 2,3) in naïve Patients Treated With Peginterferon Alpha and Ribavirin
-
CLINICAL_TRIALS study record update · 2011-04-27Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Coinfected Subjects (SLAM-C)
-
CLINICAL_TRIALS study record update · 2011-04-21Impact of Patient Support From Medical Staff on the Adherence to Therapy With PegIntron Plus Rebetol
-
CLINICAL_TRIALS study record update · 2011-04-19A Phase 1, Open Label Fixed Sequence Study To Investigate The Effects Of Multiple Oral Doses Of Filibuvir On The Steady State Pharmacokinetics Of Oral Contraceptive Steroids In Healthy Female Subjects
-
CLINICAL_TRIALS study record update · 2011-04-15Australian Trial in Acute Hepatitis C
-
CLINICAL_TRIALS study record update · 2011-04-06Reinfection Rates and Long Term Outcomes in Currently Injecting Drug Users Following Successful Treatment for Hepatitis C
-
CLINICAL_TRIALS study record update · 2011-04-04Clinical Trial of the Efficacy, Dosing, Safety and Tolerability of Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2011-02-18An Open-Label Pilot Study of the Safety, Tolerability and Anti-Viral Activity of High Dose Intravenous Ascorbic Acid in Patients Chronically Infected With Hepatitis C Virus Genotype 1, Who Have Failed Prior Therapy With Interferon-alpha and Ribavirin
-
CLINICAL_TRIALS study record update · 2011-02-09Study of Silymarin for Improving Hepatitis C
-
CLINICAL_TRIALS study record update · 2011-02-03CSP #706D - HIV Seroprevalence and Risks in Veterans With Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2011-01-24Investigation of Hepatitis B and Hepatitis C in Taiwan
-
CLINICAL_TRIALS study record update · 2011-01-10Evaluation of Rapid Virological Response in HCV Patients Treated With PegIntron and Ribavirin - APEGIN Trial
-
CLINICAL_TRIALS study record update · 2011-01-10Treatment of Chronic Hepatitis C With PegIntron Injector and Rebetol (Post Marketing Surveillance Study)
-
CLINICAL_TRIALS study record update · 2011-01-07Open-Label, Randomized, Multiple-Dose, Drug-Drug Interaction Study to Assess the Pharmacokinetics and Safety of BMS-790052 and BMS-650032 Co-administered in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2011-01-07Comparison of Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With and Without Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2010-12-30Sonazoid Enhanced Liver Cancer Trial for Early Detection
-
CLINICAL_TRIALS study record update · 2010-12-17A Phase I, Open-label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.
-
CLINICAL_TRIALS study record update · 2010-12-17A Phase I Open-label Trial to Investigate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Telaprevir.
-
CLINICAL_TRIALS study record update · 2010-12-17A Double-blind, Double-dummy, Randomized, Placebo- and Active-controlled, Four-period Crossover Trial to Evaluate the Effect of Telaprevir (TVR) on the QT/QTc Interval in Healthy Subjects